<DOC>
	<DOCNO>NCT02586844</DOCNO>
	<brief_summary>Prospective study obtain fresh tumor biopsy three blood sample patient confirm histological cytological diagnosis well-differentiated neuroendocrine tumor ( NETs ) well-differentiated pancreatic neuroendocrine tumor ( PanNETs ) molecular profiling .</brief_summary>
	<brief_title>Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors</brief_title>
	<detailed_description>In prospective study aim obtain fresh tumor biopsy three blood sample patient confirm histological cytological diagnosis well-differentiated neuroendocrine tumor ( NETs ) well-differentiated pancreatic neuroendocrine tumor ( PanNETs ) . Eligible population include : NETs PanNETs patient undergone undergoing treatment target therapy show prolonged clinical benefit , NETs PanNETs patient treat agent recently progress . RNA DNA fresh tumor biopsy mononuclear blood cell subject transcriptome sequencing DNA sequencing analysis evaluate possible gene interest relate targetable pathway . Moreover , archive tumor sample request patient perform additional genomic testing . Remaining RNA DNA bank additional exploratory analysis ( e.g . genomic testing , DNA copy number analysis , epigenetic evaluation ) .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Adenoma , Islet Cell</mesh_term>
	<criteria>Age &gt; 18 year . Histological cytological proof NETs PanNETs . At least one biopsiable lesion deem medically accessible safe biopsy . Current/recent treatment target therapy confirm clinical benefit ; confirm progression disease target therapy time study enrollment . Fulfills local institution 's laboratory parameter tumor biopsy . Willingness ability patient provide sign voluntary informed consent . Any condition could interfere ability provide inform consent dementia severe cognitive impairment . Any contraindication undergo biopsy blood collection procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>NET</keyword>
	<keyword>PanNET</keyword>
	<keyword>Molecular profiling</keyword>
	<keyword>Transcriptome sequencing</keyword>
</DOC>